Cargando…

Drug–drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case–control study in the National COVID Cohort Collaborative (N3C)

OBJECTIVE: The goal of this work is to evaluate if there is an increase in the risk of thromboembolic events (TEEs) due to concomitant exposure to dexamethasone and apixaban or rivaroxaban. Direct oral anticoagulants (DOACs), as well as corticosteroid dexamethasone, are commonly used to treat indivi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kravchenko, Olga V, Boyce, Richard D, Gomez-Lumbreras, Ainhoa, Kocis, Paul T, Villa Zapata, Lorenzo, Tan, Malinda, Leonard, Charles E, Andersen, Kathleen M, Mehta, Hemalkumar, Alexander, G Caleb, Malone, Daniel C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Pharmacology and Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806069/ https://www.ncbi.nlm.nih.gov/pubmed/36581417 http://dx.doi.org/10.1136/bmjopen-2022-066846

Ejemplares similares

Shared Decision-Making for Drug-Drug Interactions: Formative Evaluation of an Anticoagulant Drug Interaction
por: Gomez Lumbreras, Ainhoa, et al.
Publicado: (2022)

Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management
por: Hansten, Philip D., et al.
Publicado: (2022)

Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure
por: Tan, Malinda S., et al.
Publicado: (2022)

Eventos adversos en vacunas COVID-19 en una población de 5 a 17 años: estudio de la base de datos VAERS
por: Villa-Zapata, Lorenzo, et al.
Publicado: (2023)

COVID-19 vaccine adverse events in a population aged 5–17 years: a study from the VAERS database
por: Villa-Zapata, Lorenzo, et al.
Publicado: (2023)

Drug exposure during pregnancy in primary care: an algorithm and observational study from SIDIAP database, Catalunya, Spain
por: Lestón Vázquez, Marta, et al.
Publicado: (2023)

Clinical and economic impact of adverse drug reactions in hospitalised patients: prospective matched nested case–control study in Ethiopia
por: Sendekie, Ashenafi Kibret, et al.
Publicado: (2023)

Scoping review of rational polytherapy in patients with drug‐resistant epilepsy
por: Grinalds, McKenzie S., et al.
Publicado: (2022)

Alzheimer’s Disease: Understanding Its Novel Drug Delivery Systems and Treatments
por: Dhingra, Hitaansh, et al.
Publicado: (2022)

Population pharmacokinetics and pharmacodynamics of investigational regimens’ drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trial
por: Nyang'wa, Bern-Thomas, et al.
Publicado: (2021)

Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs
por: van Leeuwen, R W F, et al.
Publicado: (2013)

A Shared Decision-making Tool for Drug Interactions Between Warfarin and Nonsteroidal Anti-inflammatory Drugs: Design and Usability Study
por: Reese, Thomas J, et al.
Publicado: (2021)

A prospective study of adverse drug reactions to antiepileptic drugs in children
por: Anderson, Mark, et al.
Publicado: (2015)

Impact of changes in pill appearance in the adherence to angiotensin receptor blockers and in the blood pressure levels: a retrospective cohort study
por: Lumbreras, B, et al.
Publicado: (2017)

Drug-Drug Interaction Study of Benznidazole and E1224 in Healthy Male Volunteers
por: Ribeiro, Isabela, et al.
Publicado: (2021)

Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma
por: Wong, E T, et al.
Publicado: (2015)

Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome
por: Wei, Li, et al.
Publicado: (2008)

The Need for Uniformity in the Quality of Drugs
Publicado: (1908)

Predicting the risk of drug–drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study
por: Wolff, Jan, et al.
Publicado: (2021)

Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010–2016
por: Ardeshirrouhanifard, Shirin, et al.
Publicado: (2022)

Parasite Viability as a Measure of In Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment
por: Radohery, Georges F. R., et al.
Publicado: (2022)

Evaluation of the Prevalence and Risk Factors of Drug-Related Problems in Hypertension and Type 2 Diabetes Mellitus Patients at a Tertiary Care Hospital: A Cross-Sectional Study
por: Reddy Peddi, Divya, et al.
Publicado: (2023)

What Becomes of Some Spoiled Drugs
Publicado: (1899)

Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in Sweden
por: Loikas, Desirée, et al.
Publicado: (2013)

Effect of non-steroidal anti-inflammatory drugs on colon carcinoma Caco-2 cell responsiveness to topoisomerase inhibitor drugs
por: Ricchi, P, et al.
Publicado: (2002)

Comparative drug screening in NUT midline carcinoma
por: Beesley, A H, et al.
Publicado: (2014)

Notes on Some Remedies. XIII. Drugs in Syphilis
por: Chaudhuri, R. N.
Publicado: (1947)

Notes on Some Remedies. XVII. Drugs in Anæmias
por: Chaudhuri, R. N.
Publicado: (1948)

An Individual Participant Data Population Pharmacokinetic Meta-analysis of Drug-Drug Interactions between Lumefantrine and Commonly Used Antiretroviral Treatment
por: Francis, Jose, et al.
Publicado: (2020)

Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study
por: Sharma, Megha, et al.
Publicado: (2021)

DEXAMETHASONE PULSE THERAPY IN PATIENTS OF SYSTEMIC SCLEROSIS: IS IT A VIABLE PROPOSITION? A STUDY FROM KASHMIR
por: Sameem, Farah, et al.
Publicado: (2010)

Drug-Associated Risk Tool: development and validation of a self-assessment questionnaire to screen for hospitalised patients at risk for drug-related problems
por: Kaufmann, Carole P, et al.
Publicado: (2018)

Characterization of Differentially Detectable Mycobacterium tuberculosis in the Sputum of Subjects with Drug-Sensitive or Drug-Resistant Tuberculosis before and after Two Months of Therapy
por: Zainabadi, Kayvan, et al.
Publicado: (2021)

Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma
por: Tavanti, E, et al.
Publicado: (2013)

Notes on Some Remedies. XV. Drugs in Syphilis (Contd.)
por: Chaudhuri, R. N.
Publicado: (1947)

Notes on Some Remedies. XIV. Drugs in Syphilis (Contd.)
por: Chaudhuri, R. N.
Publicado: (1947)

How innovative are new drugs launched in the UK? A retrospective study of new drugs listed in the British National Formulary (BNF) 2001–2012
por: Ward, Derek J, et al.
Publicado: (2014)

Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses
por: Kjeldsen, Sverre E., et al.
Publicado: (2016)

Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs
por: Gelardi, T, et al.
Publicado: (2008)

Treatment with imatinib improves drug delivery and efficacy in NSCLC xenografts
por: Vlahovic, G, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_iodpkm06mb6spr0h2t0k8nlppc